| Literature DB >> 22391248 |
Seth S Martin1, Roger S Blumenthal, Michael Miller.
Abstract
High cholesterol is often a prerequisite for atherosclerotic plaque. Low-density lipoprotein cholesterol (LDL-C) is the focus of the National Cholesterol Education Program Adult Treatment Panel guidelines. LDL-C ranges from 50 to 70 mg/dL in native hunter-gatherers, healthy human neonates, free-living primates, and other wild mammals, who are notably free of atherosclerotic vascular disease. Multiple statin trials and meta-analyses support a treatment target of LDL-C levels less than 70 mg/dL, as this is associated with improved clinical outcomes and atherosclerosis regression. In fact, no threshold has yet been identified below which patients do not benefit from lowering of LDL-C. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22391248 DOI: 10.1016/j.mcna.2012.01.009
Source DB: PubMed Journal: Med Clin North Am ISSN: 0025-7125 Impact factor: 5.456